Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK3 | P52333 | 18/20 | 0.43 |
| ▸ | JAK2 | O60674 | 8/20 | 0.43 |
| ▸ | JAK1 | P23458 | 8/20 | 0.43 |
| ▸ | TYK2 | P29597 | 6/20 | 0.43 |
| ▸ | KIT | P10721 | 1/20 | 0.41 |
| ▸ | AKT2 | P31751 | 1/20 | 0.41 |
| ▸ | GSK3B | P49841 | 1/20 | 0.41 |
| ▸ | LCK | P06239 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL323030 | 0.84 | JAK3 (0.43) | JAK3JAK2JAK1TYK2AKT2 | |
| SCHEMBL323157 | 0.84 | JAK3 (0.44) | JAK3JAK2JAK1TYK2KIT | |
| SCHEMBL324141 | 0.84 | JAK3 (0.43) | JAK3JAK2JAK1TYK2AKT2 | |
| SCHEMBL324613 | 0.83 | JAK3 (0.53) | JAK3JAK2JAK1TYK2AKT2 | |
| SCHEMBL323269 | 0.82 | AKT2 (0.54) | JAK3JAK2JAK1TYK2KIT | |
| SCHEMBL323629 | 0.82 | JAK3 (0.45) | JAK3JAK2JAK1TYK2KIT | |
| SCHEMBL324666 | 0.81 | JAK3 (0.52) | JAK3JAK2JAK1TYK2KIT | |
| SCHEMBL322722 | 0.81 | AKT1 (0.54) | KITAKT2GSK3B | |
| SCHEMBL323421 | 0.80 | AKT1 (0.45) | JAK3JAK2JAK1TYK2AKT2 | |
| SCHEMBL323699 | 0.80 | RPS6KB1 (0.46) | JAK3JAK2JAK1TYK2AKT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2590981-A1 | NOVEL HOMOPIPERAZINE DERIVATIVES AS PROTEIN TYROSINE KINASE INHIBITORS AND PHARMACEUTICAL USE THEREOF | Leo Pharma A/S (DK) | 2013-05-15 | — | — | EP | claimed |
| WO-2012003829-A1 | NOVEL HOMOPIPERAZINE DERIVATIVES AS PROTEIN TYROSINE KINASE INHIBITORS AND PHARMACEUTICAL USE THEREOF | LEO PHARMA A/S (DK) | 2012-01-12 | — | — | WO | claimed |
| EP-2590981-A1 | NOVEL HOMOPIPERAZINE DERIVATIVES AS PROTEIN TYROSINE KINASE INHIBITORS AND PHARMACEUTICAL USE THEREOF | Leo Pharma A/S (DK) | 2013-05-15 | — | — | EP | disclosed |
| WO-2012003829-A1 | NOVEL HOMOPIPERAZINE DERIVATIVES AS PROTEIN TYROSINE KINASE INHIBITORS AND PHARMACEUTICAL USE THEREOF | LEO PHARMA A/S (DK) | 2012-01-12 | — | — | WO | disclosed |